Full-Time

Account Manager

Arizona

Confirmed live in the last 24 hours

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell genetic information for diagnostics

Data & Analytics
Biotechnology
Healthcare

Compensation Overview

$152k - $228kAnnually

+ Equity Grant + Incentive Compensation + Transportation Reimbursement

Junior, Mid

No H1B Sponsorship

Phoenix, AZ, USA

Category
Strategic Account Management
Sales & Account Management
Requirements
  • BA/BS or Master’s degree in Life Sciences or related field
  • Strong technical background in molecular biology, genomics, next generation sequencing or immunology a plus.
  • 5 – 7 years of successful sales experience in hematology, oncology, biotech, life science or diagnostic sales. Oncology lab service background a plus.
  • Well-developed professional and strategic selling skills with a proven ability to grow key accounts by building and leveraging networks inside and outside the life science and research areas of key institutions. Demonstrated ability to convert qualified leads into closed sales.
  • Excellent listening, time management, organizational and interpersonal skills.
  • Outstanding communication skills, including the ability to illustrate potential opportunities for our technologies applications.
  • Strategic account management, previous experience in developing & implementing attainable account-specific business plans is required.
  • Demonstrated ability to work in a team environment, with the goals of bringing the appropriate resources to a specific customer need. Excited about an early stage company environment that may require greater self-sufficiency.
  • Experience with effective utilization of salesforce.com or similar CRM database a plus.
Responsibilities
  • Establish effective territory strategies which further Adaptive’s goals in select targeted key accounts by developing account-specific business plans which prioritize and leverage internal resources.
  • Identify, develop and maintain high-value relationships with KOLs, oncologist’s, hospitals and core labs.
  • Effectively build a short/medium/long term sales pipeline and manage the necessary levels of sales leads, prospects and opportunities.
  • Build a comprehensive knowledge of customers and prospects including the overall market, customer needs, personnel and responsibilities, budgeting, knowing their funding processes and the competition.
  • Demonstrate knowledge of, access to, and the ability to influence all key stakeholders in targeted accounts. (Oncologists, BMT, Hematology Pathologist, Executive Leadership, Lab personnel, etc.)
  • Attend identified relevant national/reginal/local education meetings and conferences, maximizing opportunities at these events to deepen and expand the credibility of Adaptive.
  • Deliver compelling sales presentations: close initial business, follow-up and identify repeat business while building a network of referrals.
  • Facilitate negotiation of sales opportunities within company-established parameters, including associated purchase orders and/or quotations.
  • Participate in/facilitate account agreements, educational programs, training and customer support efforts working with Adaptive’s internal partners. (Clinical Services, Market Access, Marketing, Medical Affairs, etc.)
  • Coordinate and communicate sales activities and strategies to management while defining resource requirements.
  • Develop and maintain all account/contact details within Customer Relationship Management database (SFDC).
  • Utilize sales tracking tools to effectively monitor and direct customer purchase activities.
  • Provide regular and accurate sales forecast updates.
  • Satisfy all product and technology training requirements as established by management.
  • Comply with all Federal and State laws, regulations and policies that govern the conduct of Adaptive’s activities.
  • Business travel, by air, train or car is required for regular internal and external business meetings.
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies uses advanced data algorithms to analyze immune cell genetics and generates revenue through partnerships with pharmaceutical companies, licensing technology, and offering diagnostic services. Their goal is to leverage immune system data to advance healthcare and address various diseases.

Company Stage

IPO

Total Funding

$395.8M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

-11%

2 year growth

-15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Adaptive Biotechnologies' partnerships with pharmaceutical companies and healthcare providers offer significant growth opportunities and revenue streams.
  • Winning the Workplace of the Year Award highlights their strong company culture and employee satisfaction, making it an attractive place to work.
  • Their collaboration with BeiGene on minimal residual disease measurement could lead to groundbreaking advancements in cancer treatment.

What critics are saying

  • The departure of key board members like Kevin Conroy and Leslie Trigg could lead to strategic instability.
  • The highly competitive biotechnology sector requires continuous innovation to maintain market position.

What makes Adaptive Biotechnologies unique

  • Adaptive Biotechnologies leverages the genetic information of immune cell receptors to develop advanced diagnostic tools and treatments, setting it apart from traditional biotech firms.
  • Their ImmuneRACE study, focusing on COVID-19 immune response, showcases their commitment to addressing current global health challenges.
  • The integration of their clonoSEQ® assay with Epic systems enhances their diagnostic capabilities, providing a seamless experience for healthcare providers.

Help us improve and share your feedback! Did you find this helpful?